Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Epigenetic Reader Domain
    (1)
  • Others
    (4)
Filter
Search Result
Results for "

bd 4

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Inhibitors_Agonists
  • Recombinant Protein
    5
    TargetMol | Recombinant_Protein
Mtb-cyt-bd oxidase-IN-4
T72300
Mtb-cyt-bd oxidase-IN-4, an inhibitor of Mycobacterium tuberculosis cytochrome bd oxidase (Mtb cyt-bd oxidase), demonstrates potent activity with an IC50 value of 0.25 μM and inhibits the growth of Mycobacterium tuberculosis with a minimum inhibitory concentration (MIC) of 8 μM. This compound is utilized in tuberculosis research.
  • Inquiry Price
6-8 weeks
Size
QTY
ZL0420
T68282229039-45-4
ZL0420 is a potent and selective bromodomain-containing protein 4 (BRD4) inhibitor with nanomolar binding affinities to the bromodomains (BDs) of BRD4, exhibiting IC50 values of 27 nM against BRD4 BD1 and 32 nM against BRD4 BD2.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
BD 1008 Free Base
T70809138356-08-8
BD 1008 Free Base is a selective sigma receptor antagonist, with a reported binding affinity of Kᵢ = 2 ± 1 nM for the sigma-1 receptor and 4 times selectivity over the sigma-2 receptor.
  • Inquiry Price
1-2 weeks
Size
QTY
Mtb-cyt-bd oxidase-IN-6
T723021246461-10-8
Mtb-cyt-bd oxidase-IN-6, a potent inhibitor of Mycobacterium tuberculosis (Mtb) cytochrome bd (cyt-bd) oxidase (MtbCyt-bd Oxidase), exhibits an inhibitory concentration (IC50) of 0.35 μM and effectively suppresses Mtb growth with a minimum inhibitory concentration (MIC) of 4 μM. This compound is utilized in tuberculosis research [1].
  • Inquiry Price
6-8 weeks
Size
QTY